Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
Papadopoulou, Eirini, Loutradis, Charalampos, Tzatzagou, Glykeria, Kotsa, Kalliopi, Zografou, Ioanna, Minopoulou, Ioanna, Theodorakopoulou, Marietta P, Tsapas, Apostolos, Karagiannis, Asterios, Sarafidis, Pantelis
Published in Journal of hypertension (01.04.2021)
Published in Journal of hypertension (01.04.2021)
Get more information
Journal Article